News

Google News
juve-patent. com-patent. com

Taylor Wessing bolsters German patent practice with Eisenf'hr Speiser hires

2+ day, 20+ hour ago  (194+ words) Taylor Wessing is pushing ahead with the reorganisation of its German patent practice and is strengthening its team with two patent litigators from Eisenf'hr Speiser. Michael Schneider joins the Munich office as equity partner, Philipp Neels joins the Hamburg office…...

Symbols: btc-usd
JUVE Patent
juve-patent. com-patent. com

Head of IP at Heidelberg Pharma joins Fuchs Patentanw'lte

2+ day, 22+ hour ago  (315+ words) Frankfurt-based patent attorney firm Fuchs is expanding its life sciences practice with a senior in-house hire. Tobias Fischer, currently vice president IP at Heidelberg Pharma, will join the firm as a senior patent attorney. 15 May 2026 by Mathieu Klos Fischer brings…...

Symbols: otc:polbf
JUVE Patent
juve-patent. com-patent. com

Game over: Subsonic prevails against Sony in infringement case over Play Station controllers

4+ day, 1+ hour ago  (309+ words) Subsonic does not have to pay Sony damages for the marketing of controllers for the Play Station 4 console. Although the Court of Appeal in Paris granted the Japanese plaintiff the right to sue at the second attempt, it did not…...

Symbols: btc-usd
JUVE Patent
juve-patent. com-patent. com

"The UPC wants to bring ZTE and Samsung to the negotiating table"

4+ day, 22+ hour ago  (329+ words) 13 May 2026 by Christina Schulze It would be quite the opening act for the PMAC if it could help resolve such an extensive high-profile patent dispute between Chinese company ZTE and Korean giant Samsung. The judgments already handed down in China,…...

Symbols: btc-usd
JUVE Patent
juve-patent. com-patent. com

Belgian private equity-backed flooring company launches IP consulting service

5+ day, 21+ hour ago  (463+ words) Under the brand House of IP, the Belgian developer of floor coverings i4 F wants to offer IP services to other companies. To this end, the private equity-backed technology company wants to unite several patent attorney firms under the new brand....

Symbols: nyse:ip
JUVE Patent
juve-patent. com-patent. com

AMI fails to secure ban on Martin-Baker's ejection seats for fighter jets

6+ day, 19+ hour ago  (523+ words) 11 May 2026 by Mathieu Klos With increasing armed conflict around the world and rising military spending, military technology is once again coming into the public spotlight. For example, two of the world's largest manufacturers of ejection seats are currently battling it…...

Symbols: btc-usd,eth-usd,xrp-usd,sol-usd,nyse:itt
JUVE Patent
juve-patent. com-patent. com

HP prevails in Munich in toner cartridge dispute against Ninestar

1+ week, 2+ day ago  (550+ words) Once again, the Munich Regional Court has banned several Ninestar subsidiaries from selling certain printer cartridges in Germany. This time, however, the court ruled that the Chinese parent company can also be held liable for infringing acts against HP cartridges…...

Symbols: nyse:hpq
JUVE Patent
juve-patent. com-patent. com

UPC highly popular with Chinese and US claimants

1+ week, 3+ day ago  (262+ words) 7 May 2026 by Christina Schulze In a recent interview with JUVE Patent, Klaus Grabinski, president of the Court of Appeal, emphasised, "The case management system is absolutely crucial, as the UPC defines itself as an electronic court. It's worth noting that…...

JUVE Patent
juve-patent. com-patent. com

Partial success for Millenium Pharma in battle over Velcade in Paris

1+ week, 3+ day ago  (807+ words) In the cross-border dispute over anti-cancer drug Velcade, Millenium, Jansen and Cilag have seen a partial success in France. In a ruling handed down yesterday, the Judicial Court Paris dismissed the claims of inadmissibility filed by the generics companies. Thus,…...

Symbols: nasdaq:mrna
JUVE Patent
juve-patent. com-patent. com

UPC revokes Chinese military medical research institute's remdesivir patent

1+ week, 4+ day ago  (468+ words) Gilead has successfully contested a patent that jeopardised its business with the COVID-19 drug Veklury based on remdesivir. The Milan central division revoked the patent belonging to the Chinese research institute AMMS in its entirety and rejected its applications for…...

Symbols: nasdaq:bfri,asx:rce